WebSep 27, 2024 · 27 Sep, 2024 07:26 29 Jun, 2024 02:36 Hikma buys Custopharm for $375m Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt... WebThe up-front consideration of $375 million is on a cash-free, debt-free basis and is being funded from Hikma’s existing cash resources. The acquisition constitutes a Class 2 transaction pursuant to the UK Listing Rules. The gross assets of Custopharm at 31 December 2024 were $43 million. Losses before tax in the year to 31 December 2024 …
Hikma Pharmaceuticals/Custopharm Federal Trade …
Webof each. Hikma includes Hikma Pharmaceuticals USA Inc., and Hikma Cali Inc.. After the Acquisition, Hikma will include Custopharm. B. “Custopharm” means Custopharm, Inc. its … WebApr 19, 2024 · As part of generic drug company Hikma’s proposed $375 million acquisition of generic injectable producer Custopharm, the commission is requiring that Hikma not acquire a generic... flush gas cooktop
Hikma Buys Injectables Specialist Custopharm In $400m+ Deal
WebApr 21, 2024 · As previously announced on 27 September 2024, Hikma has acquired Custopharm for an initial cash consideration of $375 million on a debt and cash-free … WebApr 20, 2024 · Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today confirms it has received preliminary approval from the US Federal Trade Commission (FTC) and will now work ... WebJul 15, 2024 · Hikma completes acquisition of Custopharm Combination expands US Injectables portfolio and pipeline LONDON, April 21, 2024 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has completed its acquisition of Custopharm Inc. ('Custopharm') from Water … flushgate